Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia

Published:2007-10-15 Issue:8 Volume:176 Page:814-818
ISSN:1073-449X
Container-title:American Journal of Respiratory and Critical Care Medicine
language:en
Short-container-title:Am J Respir Crit Care Med

Author:

Bergeron Anne,Réa Delphine,Levy Vincent,Picard Clément,Meignin Véronique,Tamburini Jérome,Bruzzoni-Giovanelli Heriberto,Calvo Fabien,Tazi Abdellatif,Rousselot Philippe

Publisher

American Thoracic Society

Subject

Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference20 articles.

1. Discovery of N-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

2. Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells

3. Dasatinib in Imatinib-Resistant Philadelphia Chromosome–Positive Leukemias

4. Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

5. Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

Cited by 170 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An association between Dasatinib, elevated left atrial pressure and pleural effusion;International Journal of Cardiology;2024-09

2. Ascites does not accompany pleural effusion developing under dasatinib therapy in patients with CML-CP;Pleura and Peritoneum;2024-02-28

3. Optimisation du bosutinib dans la leucémie myéloïde chronique : recommandations du Fi-LMC (France Intergroupe des leucémies myéloïdes chroniques);Bulletin du Cancer;2024-01

4. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management;Signal Transduction and Targeted Therapy;2023-07-07

5. Pleural effusion as the presenting feature in chronic myeloid leukemia;Muller Journal of Medical Sciences and Research;2023-07